BAY 1214784
oral hGnRH-R hormone receptor antagonist to treat of uterine fibroids, Ph. I completed from cell-based 2.5M cmpd HTS + opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Berlin, DE
Molecules of the Month - 2020 Molecules of the Year Nominees